{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:16Z","timestamp":1783138636006,"version":"3.54.6"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.2169\/internalmedicine.6401-25","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:18Z","timestamp":1763589978000},"page":"1737-1745","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between Running Average of Serum Uric Acid Levels and Clinical Course in Secondary Prevention of Coronary Artery Disease"],"prefix":"10.2169","volume":"65","author":[{"given":"Ichiro","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kagari","family":"Mukaida","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Wada","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kurozumi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunetatsu","family":"Namba","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Takagi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, KKR Takamatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci 22: 9221, 2021.","DOI":"10.3390\/ijms22179221"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol 78: 51-57, 2021.","DOI":"10.1016\/j.jjcc.2020.12.013"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410, 2000.","DOI":"10.1001\/jama.283.18.2404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Okura T, Higaki J, Kurata M, et al.; the JCAD Study Investigation. Elevated serum uric acid level is an independent predictor of cardiovascular events in patients with severe coronary artery stenosis - sub-analysis of the Japanese Coronary Artery Disease (JCAD) study -. Circ J 73: 885-891, 2009.","DOI":"10.1253\/circj.CJ-08-0828"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Niskanen LK, Laaksonen DE, Nyyss\u00f6nen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164: 1546-1551, 2004.","DOI":"10.1001\/archinte.164.14.1546"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord 16: 207, 2016.","DOI":"10.1186\/s12872-016-0379-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 62: 170-180, 2010.","DOI":"10.1002\/acr.20065"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang W, Iso H, Murakami Y, et al.; EPOCH-JAPAN GROUP. Serum uric acid and mortality from cardiovascular disease: EPOCH-JAPAN study. J Atheroscler Thromb 23: 692-703, 2016.","DOI":"10.5551\/jat.31591"},{"key":"9","unstructured":"9. Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 39: 3021-3104, 2018."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vaccarino V, Krumholz HM. Risk factors for cardiovascular disease: one down, many more to evaluate. Ann Intern Med 131: 62-63, 1999.","DOI":"10.7326\/0003-4819-131-1-199907060-00012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Alderman MH. Serum uric acid as a cardiovascular risk factor for heart disease. Curr Hypertens Rep 3: 184-189, 2001.","DOI":"10.1007\/s11906-001-0036-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med May 120: 442-447, 2007.","DOI":"10.1016\/j.amjmed.2006.06.040"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takae K, Nagata M, Hata J, et al. Serum uric acid as a risk factor for chronic kidney disease in a Japanese community - the Hisayama Study -. Circ J 80: 1857-1862, 2016.","DOI":"10.1253\/circj.CJ-16-0030"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131: 7-13, 1999.","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tian X, Wang A, Wu S, et al. Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and all-cause mortality. J Am Heart Assoc 10: e020180, 2021.","DOI":"10.1161\/JAHA.120.020180"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Adomako E, Moe OW. Uric acid and urate in urolithiasis: the innocent bystander, instigator, and perpetrator. Semin Nephrol 40: 564-573, 2020.","DOI":"10.1016\/j.semnephrol.2020.12.003"},{"key":"17","unstructured":"17. Hisatome I, Ichida K, Mineo I, et al. Japanese Society of Gout and Uric & Nucleic Acids 2019 Guidelines for Management of Hyperuricemia and Gout 3rd edition. Gout Uric Nucleic Acids 44 Supplement: 1-39, 2020."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2: e76, 2005.","DOI":"10.1371\/journal.pmed.0020076"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yu MA, S\u00e1nchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28: 1234-1242, 2010.","DOI":"10.1097\/HJH.0b013e328337da1d"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16: 3553-3562, 2005.","DOI":"10.1681\/ASN.2005050572"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Joe M, McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.","DOI":"10.1056\/NEJM198501173120305"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33: 774-797, 2002.","DOI":"10.1016\/S0891-5849(02)00956-5"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Spiekermann S, Landmesser U, Dikalov S, et al. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107: 1383-1389, 2003.","DOI":"10.1161\/01.CIR.0000056762.69302.46"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cho SK, Chang Y, Kim I, Ryu S. U-shaped association between serum uric acid level and risk of mortality: a cohort study. Arthritis Rheumatol 70: 1122-1132, 2018.","DOI":"10.1002\/art.40472"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Matsumoto I, Moriya S, Kurozumi M, Namba T, Takagi Y. Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention. J Cardiol 78: 550-557, 2021.","DOI":"10.1016\/j.jjcc.2021.08.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sugihara S, Hisatome I, Kuwabara M, et al. Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J 79: 1125-1132, 2015.","DOI":"10.1253\/circj.CJ-14-1267"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38: 365-371, 2001.","DOI":"10.1097\/00005344-200109000-00005"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6401-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:30:27Z","timestamp":1783135827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6401-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6401-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"6401-25"}}